Table 1.
Levosimendan (n = 20) | Non-levosimendan (n = 20) | p-value | |
---|---|---|---|
Male, n (%) | 9 (45%) | 12 (60%) | 0.749 |
Age at operation, months, mean ± SD | 7.5 (3.0–13.5) | 8.5 (6.0–21.3) | 0.532 |
Height, cm, median (IQR) | 68.5 (60.0–74.8) | 73.5 (66.3–89.3) | 0.088 |
Weight, kg, median (IQR) | 6.5 (5.4–8.9) | 8.5 (6.6–10.8) | 0.058 |
Left ventricular aneurysm, n (%) | 1 (5%) | 4 (20%) | 0.342 |
Concomitant mitral annuloplasty, n (%) | 8 (40%) | 7 (35%) | 0.744 |
LVEF | <0.01 | ||
<20%, n (%) | 13 (75%) | 2 (10%) | |
20–30%, n (%) | 3 (15%) | 7 (35%) | |
30–50%, n (%) | 4 (20%) | 11 (55%) | |
CPB, min, median (IQR) | 102.0 (88.3–126.8) | 105.5 (94.5–116.5) | 0.850 |
Aortic cross-clasp, min, median (IQR) | 60.5 (48.0–71.0) | 67.0 (53.5–89.3) | 0.176 |
LVEF, left ventricular ejection fraction; CPB, cardiopulmonary bypass.